| | | | | |
| €37,0401 | +1,77% | €1,64B | €5,34K | |
| €26,7669 | -3,00% | €1,63B | €238,74K | |
RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | €3,0294 | +1,59% | €1,63B | €2,29M | |
| €28,2356 | -1,43% | €1,63B | €25,84K | |
STEL Stellar Bancorp, Inc. | €32,1502 | +1,16% | €1,63B | €18,57K | |
NUV Nuveen Municipal Value Fund, Inc. | €7,7733 | -0,17% | €1,63B | €21,14K | |
BLDP Ballard Power Systems Inc. | €5,0232 | -3,55% | €1,62B | €1,66M | |
NAC Nuveen California Quality Municipal Income Fund | €10,3687 | +0,12% | €1,62B | €44,60K | |
BWIN The Baldwin Insurance Group, Inc. Class A Common Stock | €17,0333 | +5,59% | €1,62B | €75,21K | |
MESO Mesoblast Limited American Depositary Shares | €12,8257 | +2,78% | €1,62B | €18,65K | |
PRKS United Parks & Resorts Inc. | €34,3537 | +2,31% | €1,62B | €30,49K | |
RAPP Rapport Therapeutics, Inc. Common Stock | €32,1519 | +1,11% | €1,62B | €6,23K | |
SRPT Sarepta Therapeutics,, Inc. Common Stock | €14,2179 | +1,87% | €1,62B | €115,03K | |
ABCL AbCellera Biologics Inc. Common Shares | €5,1341 | +4,44% | €1,61B | €920,60K | |
SONO Sonos, Inc. Common Stock | €13,7616 | +1,86% | €1,61B | €34,29K | |
